BIROn - Birkbeck Institutional Research Online

    Fast-growing, non-infectious and intracellularly surviving drug resistant Mycobacterium aurum: a model for high-throughput antituberculosis drug screening

    Gupta, Antima and Bhakta, Sanjib and Kundu, S. and Gupta, M. and Srivastava, B.S. and Srivastava, R. (2009) Fast-growing, non-infectious and intracellularly surviving drug resistant Mycobacterium aurum: a model for high-throughput antituberculosis drug screening. Journal of Antimicrobial Chemotherapy 64 (4), pp. 774-781. ISSN 0305-7453.

    [img] Text
    2009_Gupta_A_2009_JAC.pdf - Published Version of Record
    Restricted to Repository staff only

    Download (247kB) | Request a copy

    Abstract

    Objectives: Enoyl acyl-carrier-protein reductase (InhA), the primary endogenous target for isoniazid and ethionamide, is crucial to type-II fatty acid biosynthesis (FAS-II). The objectives of this study were first to generate InhA mutants of Mycobacterium aurum, secondly to characterize InhA-mediated isoniazid and ethionamide resistance mechanisms across those mutants and finally to investigate the interaction of InhA with enzymes in the FAS-II pathway in M. aurum. Methods: Spontaneous mutants were generated by isoniazid overdose and limited broth dilution, while for genetically modified mutants sense–antisense DNA technology was used. Southern hybridization and immunoprecipitation were both used to identify the InhA homologue in M. aurum. The latter method was further used to compare the level of InhA expression in M. aurum with that in corresponding mutants. Isoniazid/ethionamide susceptibility modulation was examined in vitro and ex vivo using a resazurin assay as well as by cfu counting. In addition, circular dichroism and the bacterial twohybrid system were exploited to investigate the interaction of InhA with other enzymes of the FAS-II pathway. Results: A Mycobacterium tuberculosis InhA homologue was detected in M. aurum. Susceptibility to isoniazid/ethionamide was significantly altered in genetically modified mutants and simultaneously InhA was overexpressed in both spontaneous and genetically modified mutants. InhA interacts with other FAS-II enzymes of M. aurum in vivo. Conclusion: Close resemblance of isoniazid/ethionamide action on InhA between M. tuberculosis and M. aurum further supports the use of fast-growing and intracellularly surviving drug-resistant M. aurum to substitute for highly virulent, extremely slow-growing M. tuberculosis strains in the early stage of antituberculosis inhibitor screening.

    Metadata

    Item Type: Article
    Keyword(s) / Subject(s): antibacterial drug screening, drug resistance, enoyl acyl-carrier-protein reductase, protein–protein interaction, surrogate
    School: Birkbeck Schools and Departments > School of Science > Biological Sciences
    Research Centre: Structural Molecular Biology, Institute of (ISMB)
    Depositing User: Antima Gupta
    Date Deposited: 30 Nov 2011 11:42
    Last Modified: 06 Dec 2016 11:17
    URI: http://eprints.bbk.ac.uk/id/eprint/4441

    Statistics

    Downloads
    Activity Overview
    1Download
    951Hits

    Additional statistics are available via IRStats2.

    Archive Staff Only (login required)

    Edit/View Item Edit/View Item